Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 21;36(7):1947–1950. doi: 10.1038/s41375-022-01592-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022, corrected Publication 2022

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 2 — Clonality of T and NK cell expansions was assessed in a cohort of 12 h-MDS patients enrolled within the FISiM-hMDS14 sub-study and data were evaluated according to patients IPSS-R. T cell clonal expansions are represented in purple, while NK cell clonal expansions are represented in pink. A peculiar associations of T-cell clones with HR h-MDS and of clonal NK cell expansions with LR h-MDS was observed. No contemporary detection of clonal T and NK cell populations was found. In two patient (#7 and #12) any clonality was detected. Note: h-MDS, hypocellular myelodysplastic syndromes; HR higher risk; IPSS-R Revised International Prognostic Scoring System; LR lower risk; NK natural killer.